JP

Jyotirmayee Pati

Active Director Director DIN 09614756
DIN 09614756 First appointment May 2022 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2022
Shareholding value •••• Premium profile

About Jyotirmayee Pati

Data last updated:

Jyotirmayee Pati is a Director at Define Pharmaceuticals Private Limited (since 2022). The company operates in Trading. Define Pharmaceuticals Private Limited reported revenue of ₹5 Lakh (FY 2026).

DIN 09614756
Primary Designation Director
Industry Trading
First Appointment 23 May 2022
Oldest Company Age 4 yrs
Largest company Define Pharmaceuticals Private Limited · ₹5 Lakh (FY 2026)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 May 20222022₹5 Lakh (FY 2026)Active

Board colleagues of Jyotirmayee Pati

NameDINCompanyDesignation
Sanyasi Pradhan09614755Define Pharmaceuticals Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Define Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Jyotirmayee Pati

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jyotirmayee Pati

Jyotirmayee Pati currently holds 1 directorship: Define Pharmaceuticals Private Limited (Director, since 23 May 2022, revenue ₹5 Lakh (FY 2026)).

Jyotirmayee Pati was first appointed on 23 May 2022 as Director at Define Pharmaceuticals Private Limited.

The current boards of Jyotirmayee Pati's companies include Sanyasi Pradhan (Define Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available